Global Data: Trump's move to transform US pharma manufacturing raises doubts over its effectiveness
This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential effectiveness, says GlobalData.
GlobalData Analysts Highlight Uncertainty Around N | 10/06/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy